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 In view of preparing ourselves for the possible rise of Corona Virus 
Disease (COVID-19) cases, we have proposed a hypothetical model of 
disease course in COVID-19 patients admitted in Patan Hospital and the 
exit plan based on available evidences. This will give us a scientific basis 
of planning discharge of our future cases. According to it, patients are 
subjected to repeat Polymerase chain reaction (PCR) on day 20 of illness 
onset and then every 4 days till negative result. Patients with two 
negative PCR test repeated 24 hours apart are discharged and advised for 
14 days’ home quarantine. 
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The corona virus disease (COVID-19) has 
progressed to a global pandemic with 
significant morbidity and mortality. Nepal has 
also reported COVID-19 cases. Patan Hospital 
(PH), a teaching hospital of Patan Hospital, 
Patan Academy of Health Sciences (PAHS), 
located in Lalitpur district, Kathmandu. It has 
been allocated for management of COVID-19 
patients by ministry of health and population 
of government of Nepal. Looking at the trend 
of cases throughout the world, we believe 
Nepal wouldn’t be an exception and cases are 
likely to rise. So, in view of preparing 
ourselves for the possible rise, we propose a 
hypothetical model of disease course in our 
COVID-19 patients and the exit plan 
(discharge) based on this which will help in 
managing future cases. 
 
Cases at Patan Hospital- As a part of 
screening, three patients who had together 
travelled back to Kathmandu were tested 
positive by rapid diagnostic test (RDT). They 
had returned to Nepal 28 days back and were 
asymptomatic at the time of testing. 
Polymerase Chain Reaction (PCR) was done, 
two tested positive (case 2 and case 3). They 
are asymptomatic and are being managed in 
COVID-19 ward. Patient with negative PCR 
(case 1) was discharged and advised for 14 
days home quarantine. Rest two patients 
tested negative after six days. 
 
Table 1. Hypothetical model of the disease course of three COVID-19 patients managed at Patan Hospital 
 
 
Day Case 1 Case 2 Case 3 
1 Incubation period (IP) – D1 – Return to Nepal Return to Nepal Return to Nepal 
2 IP    
3 IP   
4 IP   
5 IP – D5   
6 Viral shedding (VS) – D1 IP – D1 IP – D1 
7 VS – IgM  IP  IP  
8 VS  - IgM  IP  IP  
9 VS - IgM IP  IP  
10 VS –  IgM IP – D5 IP – D5 
11 VS – IgM VS – D1 VS – D1 
12 VS–  IgM VS – IgM  VS – IgM  
13 VS –  IgM VS  - IgM  VS  - IgM  
14 VS –  IgM IgG VS – IgM VS – IgM 
15 VS –  IgM IgG VS –  IgM VS –  IgM 
16 VS –  IgM IgG VS – IgM VS – IgM 
17 VS – IgM IgG VS–  IgM VS–  IgM 
18 VS–  IgM IgG VS –  IgM VS –  IgM 
19 VS –  IgM IgG VS –  IgM IgG VS –  IgM IgG 
20 VS –  IgM IgG VS –  IgM IgG VS –  IgM IgG 
21 VS -  IgG VS –  IgM IgG VS –  IgM IgG 
22 VS – IgG VS – IgM IgG VS – IgM IgG 
23 VS-  IgG VS–  IgM IgG VS–  IgM IgG 
24 VS –  IgG VS –  IgM IgG VS –  IgM IgG 
24 VS – D20 IgG VS –  IgM IgG VS –  IgM IgG 
26 VS –  IgG VS -  IgG VS -  IgG 
27 VS –  IgG VS – IgG VS – IgG 
28 VS –  IgG VS-  IgG VS-  IgG 
29 Negative - D24 IgG VS –  IgG VS –  IgG 
30  VS – D20 IgG VS – D20 IgG 
31  VS –  IgG VS –  IgG 
32  VS –  IgG VS –  IgG 
33  VS –  IgG VS –  IgG 
34  VS – D24 IgG VS – D24 IgG 
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COVID-19 incubation period and viral load- In 
order to propose a hypothetical model of the 
disease course, we need to know about the 
incubation period and duration of viral 
shedding of SARS-CoV-2. As per the available 
evidence on COVID-19, median incubation 
period is 5.1 days (95% CI, 4.5 to 5.8 days), 
and 97.5% of those who develops symptoms 
within 11.5 days (CI, 8.2 to 15.6 days) of 
infection.1 However, the incubation period 
has been reported up to 24 days.2 Five 
percentage of patients are asymptomatic and 
more than 80% have mild disease.3 Viral loads 
are relatively less in asymptomatic patients.4 
Mild cases has been reported to have an early 
viral clearance, with 90% of these patients 
testing negative on PCR by day 10 post-onset 
whereas severe cases tested positive beyond 
10 days.5 The median duration of viral 
shedding as reported in a study was 20 days 
(IQR 17.0–24.0) from illness onset in survivors 
and longest duration was 37 days. The virus 
was detected until death in non-survivors.6 
The IgM antibody appears by day 7 and 
disappears by day 21 whereas IgG appears by 
day 14 and persists thereafter.7 
 
Hypothetical model- Taking the upper limit of 
all values i.e. incubation period of 5.8 days, 
viral shedding of 24 days, appearance of IgM 
antibody by day 7 clearance by day 21 and 
appearance of IgG antibody by day 14, a 
model of the disease course in our three cases 
is shown in Table 1. On the day when PCR was 
done, case 1 had undetectable viral load 
whereas IgG was present which resulted in 
antibody test positive but PCR negative. Case 
2 and case 3 would have detectable viral load 
and IgG resulting in positive antibody and PCR 
test. So, if case 1 is PCR negative on day 1, 
then case 2 and case 3 would be PCR negative 
after 6 days. For discharge, PCR must be 
negative twice from samples collected at least 
24 hours apart.8 There is a possibility of re-
infection after discharge but it is not clear 
whether a positive result is more a detection 
of the remained virus transferred from the 
lower respiratory tract to the throat or nose 
with coughs, rather than an indicator of the 
re-infection of the upper respiratory tract.9 
Exit Plan- Based on the model, the following 
exit plans were proposed for admitted cases: 
1. Once case is confirmed with PCR, it can be 
repeated on day 20 of illness onset and 
then every 4 days till first negative result 
whichever comes earlier. 
2. Test (PCR) may come positive till 5 to 6 
weeks. 
3. Once the first PCR is negative, it is 
repeated after 24 hours. 
4. If two PCRs repeated 24 hours apart are 
negative, patients can be discharged and 
advised for 14 days’ home quarantine and 
follow up on day 7 of home quarantine. 
5. On day 7 PCR is done to rule out re-
infection or residual disease if patient is 
symptomatic. 
6. If PCR is positive on day 7, patients are 
readmitted and if negative patients are 
advised to follow up on day 14. 
7. Patients who are asymptomatic on day 14 
are discharged from follow up. 
8. However, if patients have persistent or 
increased symptoms PCR is repeated on 
day 14. Discharge from follow up to be 
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